Construct a safety implementation process of domiciliary subcutaneous injection of biological agents in the department of rheumatology
10.3760/cma.j.issn.1672-7088.2018.27.007
- VernacularTitle:风湿病患者居家皮下注射生物制剂安全实施流程的构建
- Author:
Ru JIA
1
;
Qingfen LIU
Author Information
1. 201999,上海交通大学医学院附属第九人民医院急诊科
- Keywords:
Patients in department of rheumatology;
Biological agent;
Subcutaneous injection;
Delphi method;
Domiciliary process
- From:
Chinese Journal of Practical Nursing
2018;34(27):2112-2115
- CountryChina
- Language:Chinese
-
Abstract:
Objective To ensure the effectiveness and safety of domiciliary subcutaneous injection of biological agents, a safety implementation process was constructed for the treatment of patients with rheumatic diseases by domiciliary subcutaneous injection of biological agents. Methods Based on analyzing the existing clinical work and consulting the relevant documents, using Delphi expert consultation method, 10 experts and 30 patients were treated with 2 rounds of questionnaire to conduction. Results After 2 rounds of expert consultation, the safety implementation process was developed, including 7 items and 27 sub-items. The positive coefficient of the experts was 100％ and 90％respectively, the authority coefficient was 0.84, and the sub projects coordination coefficient was 0.454. Conclusions On the clauses in the safety implementation process of the domiciliary subcutaneous injection of biological agents in the Department of rheumatism which constructed with the Delphi method, experts opinions was consistence, having high credibility of the research results. By systematically managing the home patients who receiving the injective biological agents, transferring the part of the simple treatment from the hospital to the home was acceptance, the effectiveness and safety of domiciliary injection was improved.
